Clarithromycin resistance and point mutations in the 23S rRNA gene in Helicobacter pylori isolates from Malaysia

Journal of Digestive Diseases

Volumn 11, Issue 2, 2010, Pages 101-105

  Ho, Sin Loong ^a   Tan, Eng Lai ^b   Sam, Chook Koon ^a   Goh, Khean Lee ^b  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Clarithromycin resistance; PCR restriction fragment length polymorphism (PCR RFLP)

Indexed keywords

CLARITHROMYCIN; PEPTIDYLTRANSFERASE; PRIMER DNA; RIBOSOME RNA; ANTIINFECTIVE AGENT; RNA 23S;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; DNA EXTRACTION; FEMALE; GASTROINTESTINAL DISEASE; GASTROSCOPY; GENE AMPLIFICATION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MALAYSIA; MALE; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RNA GENE; STOMACH BIOPSY; TISSUE SECTION; BIOPSY; GENETICS; HELICOBACTER INFECTION; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; PREVALENCE; RETROSPECTIVE STUDY; STOMACH;

ADULT; ANTI-BACTERIAL AGENTS; BIOPSY; CLARITHROMYCIN; DRUG RESISTANCE, BACTERIAL; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALAYSIA; MALE; MIDDLE AGED; POINT MUTATION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREVALENCE; RETROSPECTIVE STUDIES; RNA, RIBOSOMAL, 23S; STOMACH;

EID: 77954741567     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/j.1751-2980.2010.00423.x     Document Type: Article

References (33)

1. Lam SK, Talley NJ. Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol 1998, 13:1-12.
2. Malfertheiner P, Megraud F, O'Morain C. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007, 56:772-81.
3. Hu FL, Hu PJ, Liu WZ. Third Chinese National Consensus Report on the management of Helicobacter pylori infection. J Dig Dis 2008, 9:178-84.
4. Goh KL, Mahendraraj S, Parasakthi N, Kew ST, Kandasami P, Mazlam Z. Management of Helicobacter pylori infection: Working Party Report of the Malaysian Society of Gastroenterology and Hepatology. Med J Malaysia 1998, 53:302-10.
5. Lind T, Veldhuyzen van Zanten SJO, Unge P. Eradication of Helicobacter pylori using one week triple therapies combining omeprazole with two antimicrobials. The MACH 1 study. Helicobacter 1996, 1:138-44.
6. Misiewicz JJ, Harris AW, Bardhan KD. One-week low-dose triple therapy for eradication of H. pylori: a large multicentre randomised trial. Gut 1997, 41:735-9.
7. Lind T, Megraud F, Unge P. The MACH 2 Study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies. Gastroenterology 1999, 116:248-53.
8. Ling TKW, Cheng FB, Sung JJY, Yiu YL, Chung SCS. An increase in Helicobacter pylori strains resistant to metronidazole: a five-year study. Helicobacter 1996, 1:57-61.
9. Wong BCY, Wong WM, Wang WH. One-week ranitidine bismuth citrate-based triple therapy for the eradication of Helicobacter pylori in Hong Kong with high prevalence of metronidazole resistance. Aliment Pharmacol Ther 2001, 15:403-9.
10. Goh KL, Parasakthi N, Cheah PL, Ranjeev P, Tan YM, Chin SC. The efficacy of a one-week pantoprazole triple therapy in eradicating Helicobacter pylori in Malaysian patients. J Gastroenterol Hepatol 2000, 15:910-4.
11. Goh KL. Update in the management of Helicobacter pylori infection including for drug-resistant organisms. J Gastroenterol Hepatol 2002, 17:482-7.
12. Houben MHMG, van de Beck D, Hensen EF, Craen AJM, Rauws EAJ, Tytgat GNJ. A systematic review of Helicobacter pylori eradication therapy - the impact of antimicrobial resistance on eradication rates. Aliment Pharmacol Ther 1999, 13:1047-55.
13. Kto M, Yamaoka Y, Kim JJ. Regional differences in metronidazole resistance and increasing clarithromycin among Helicobacter pylori isolates from Japan. Antimicrob Agents Chemother 2000, 44:2214-6.
14. Torres J, Camorlinga-Ponce M, Perez-Perez G. Increasing multidrug resistance in Helicobacter pylori strains isolated from children and adults in Mexico. J Clin Microbiol 2001, 39:2677-80.
15. Prazeres Magalhaes P, De Magalhaes Queiroz DM, Campos Barbosa DV. Helicobacter pylori primary resistance to metronidazole and clarithromycin in Brazil. Antimicrob Agents Chemother 2002, 46:2021-3.
16. De Francesco V, Margiotta M, Zullo A. E. Prevalence of primary clarithromycin resistance in Helicobacter pylori strains over a 15 year period in Italy. J Antimicrob Chemother 2007, 59:783-5.
17. Hu CT, Wu CC, Lin CY. Resistance rate to antibiotics of Helicobacter pylori isolates in eastern Taiwan. J Gastroenterol Hepatol 2007, 22:720-3.
18. Parasakthi N, Goh KL. Primary and acquired clarithromycin resistance amongst Helicobacter pylori strains in Malaysia. Am J Gastroenterol 1995, 90:519.
19. Goh KL, Parasakthi N, Chuah SY, Cheah PL, Lo YL, Chin SC. One-week low dose triple therapy with proton-pump inhibitors - optimal therapy for H. pylori eradication? Alim Pharm Ther 1997, 11:1115-8.
20. Goh KL, Parasakthi N, Cheah PL. The efficacy of a one week pantoprazole triple therapy in eradicating Helicobacter pylori in Malaysian patients. J Gastroenterol Hepatol 2000, 15:910-4.
21. Goh KL, Qua CS, Manikam J, Parasakthi N. Helicobacter resistance to antibiotics in Malaysia. J Gastroenterol Hepatol 2008, 23(5):A117. Suppl
22. Versalovic J, Shortridge D, Kibler K. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother 1996, 477-80.
23. Goh KL, Parasakthi N, Peh SC, Puthucheary SD, Wong NW. Rapid urease test in the diagnosis of Helicobacter pylori infection. Sing Med J 1994, 35:161-2.
24. Taylor DE, Ge Z, Purych D, Lo T, Hiratsuka K. Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations. Antimicrob Agents Chemother 1997, 41:2621-8.
25. Occhialini A, Urdaci M, Doucer-Populaire F, Bebear CM, Lamouliatte H, Megarud F. Macrolide resistance in Helicobacter pylori: rapid detection of point mutations and assays of macrolide binding to ribosome. Antimicrob Agents Chemother 1997, 41:2724-8.
26. Stone GG, Shortridge D, Versalovic J. A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori. Antimicrob Agents Chemother 1997, 41:712-4.
27. Weisblum B. Erythromycin resistance by ribosome modification. Antimicrob Agents Chemother 1995, 39:577-85.
28. Nakajima Y. Mechanisms of bacterial resistance to macrolide antibiotics. J Infect Chemother 1999, 5:61-74.
29. Debets-Ossenkopp YJ, Sparrius M, Kusters JG, Kolkmann JJ, Vanderbroucke-Grauls CM. Mechanism of clarithromycin resistance in clinical isolates of Helicobacter pylori. FEMS Microbiol Lett 1996, 142:37-42.
30. Pina M, Occhialini A, Monteriro L, Doermann HP, Megraud F. Detection of point mutations associated with resistance of Helicobacter pylori to clarithromycin by hybridization in liquid phase. J Clin Microbiol 1998, 36:3285-90.
31. Marais A, Monteiro L, Occhialin A, Pina M, Lamouliatte H, Megraud F. Direct detection of Helicobacter pylori resistance to macrolides by a polymerase chain reaction/DNA enzyme immunoassay in gastric biopsy specimens. Gut 1999, 44:463-7.
32. Wang WH, Wong BCY, Mukhopadhyay AK. High prevalence of Helicobacter pylori infection with dual resistance to metronidazole an clarithromycin in Hong Kong. Aliment Pharmacol Ther 2000, 14:901-10.
33. Kim KS, Kang JO, Eun CS, Han DS, Choi TY. Mutations in the 23S rRNA gene of Helicobacter pylori associated with clarithromycin resistance. J Korean Med Sci 2002, 17:599-603.